Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 4:57 PM View:  | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 03-May-24 | Grant | 4,748,340 | -- | -- | 116% 4.1M to 8.85M | |
| 16-Apr-24 8:35 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 12-Apr-24 | Grant | 3,280,620 | -- | -- | 398% 824.22K to 4.1M | |
| 27-Feb-24 4:31 PM View: | Sperzel John J III See Remarks Director | T2 Biosystems, Inc. (TTOO) | 24-Feb-24 | Option Exercise | 67 | -- | -- | 20% 0.33K to 0.4K | |
| 27-Feb-24 4:30 PM View: | Sprague John M Chief Financial Officer | T2 Biosystems, Inc. (TTOO) | 24-Feb-24 | Option Exercise | 29 | -- | -- | 26% 0.11K to 0.14K | |
| 27-Feb-24 4:30 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 24-Feb-24 | Option Exercise | 29 | -- | -- | 27% 0.11K to 0.14K | |
| 20-Feb-24 4:00 PM View: | Giffin Brett A. Chief Commercial Officer | T2 Biosystems, Inc. (TTOO) | 20-Feb-24 | Option Exercise | 13 | -- | -- | 20% 64 to 77 | |
| 20-Feb-24 4:00 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 20-Feb-24 | Option Exercise | 40 | -- | -- | 61% 66 to 0.11K | |
| 20-Feb-24 4:00 PM View: | Sprague John M Chief Financial Officer | T2 Biosystems, Inc. (TTOO) | 20-Feb-24 | Option Exercise | 40 | -- | -- | 56% 72 to 0.11K | |
| 20-Feb-24 4:00 PM View: | Sperzel John J III See Remarks Director | T2 Biosystems, Inc. (TTOO) | 20-Feb-24 | Option Exercise | 160 | -- | -- | 92% 0.17K to 0.33K | |
| 16-Feb-24 5:17 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 14-Feb-24 | Conversion | 824,220 | -- | -- | 100% 0 to 824.22K | |
| 28-Nov-23 4:05 PM View: | Giffin Brett A. Chief Commercial Officer | T2 Biosystems, Inc. (TTOO) | 08-Nov-23 | Option Exercise | 33 | -- | -- | 106% 31 to 64 | |
| 20-Oct-23 4:16 PM View: | Adams Laura Lee Director | T2 Biosystems, Inc. (TTOO) | 18-Oct-23 | Option Exercise | 7 | -- | -- | 23% 30 to 37 | |
| 29-Sep-23 4:30 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 28-Sep-23 | Sale | 7,148,940 | $0.16 | $1,125,960.00 | (100%) 7.15M to 0 | |
| 29-Sep-23 4:30 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 27-Sep-23 | Sale | 5,981,200 | $0.19 | $1,146,000.00 | (46%) 13.13M to 7.15M | |
| 28-Sep-23 4:30 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 26-Sep-23 | Sale | 5,392,920 | $0.20 | $1,082,360.00 | (29%) 18.52M to 13.13M | |
| 27-Sep-23 5:53 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 25-Sep-23 | Sale | 250,000 | $0.25 | $62,500.00 | (1%) 18.77M to 18.52M | |
| 26-Sep-23 5:15 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 22-Sep-23 | Sale | 5,079,340 | $0.26 | $1,314,530.00 | (21%) 23.85M to 18.77M | |
| 25-Sep-23 8:30 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 21-Sep-23 | Sale | 6,338,210 | $0.30 | $1,904,630.00 | (21%) 30.19M to 23.85M | |
| 22-Sep-23 4:15 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 20-Sep-23 | Sale | 7,753,710 | $0.31 | $2,408,300.00 | (20%) 37.94M to 30.19M | |
| 21-Sep-23 4:30 PM View: | Capital Royalty L.P. 10% Owner | T2 Biosystems, Inc. (TTOO) | 19-Sep-23 | Sale | 10,401,500 | $0.37 | $3,806,940.00 | (22%) 48.35M to 37.94M | |
| 11-Oct-23 5:00 PM View: | Elsbree David B Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,300 | -- | -- | 40% 5.72K to 8.02K | |
| 11-Oct-23 5:00 PM View: | Liebman Seymour Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,300 | -- | -- | 49% 4.7K to 7.0K | |
| 11-Oct-23 5:00 PM View: | Saunders Ninfa Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,300 | -- | -- | 46% 5.02K to 7.32K | |
| 11-Oct-23 5:00 PM View: | Toft Robin Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,300 | -- | -- | 66% 3.47K to 5.77K | |
| 11-Oct-23 5:00 PM View: | Cumming John W Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,600 | -- | -- | 98% 2.66K to 5.26K | |
| 11-Oct-23 5:00 PM View: | Adams Laura Lee Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,300 | -- | -- | 314% 0.73K to 3.03K | |
| 11-Oct-23 5:00 PM View: | Bernard Thierry Director | T2 Biosystems, Inc. (TTOO) | 15-Sep-23 | Option Exercise | 2,300 | -- | -- | 46% 5.02K to 7.32K | |
| 16-Aug-23 4:01 PM View: | Bernard Thierry Director | T2 Biosystems, Inc. (TTOO) | 06-Aug-23 | Option Exercise | 454 | -- | -- | 10% 4.57K to 5.02K | |
| 16-Aug-23 4:00 PM View: | Saunders Ninfa Director | T2 Biosystems, Inc. (TTOO) | 06-Aug-23 | Option Exercise | 454 | -- | -- | 10% 4.57K to 5.02K | |
| 16-Aug-23 4:00 PM View: | Toft Robin Director | T2 Biosystems, Inc. (TTOO) | 06-Aug-23 | Option Exercise | 454 | -- | -- | 15% 3.02K to 3.47K | |
| 06-Apr-23 1:08 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 28-Mar-23 | Market Sale (Planned) | 239 | $0.48 | $114.96 | (3%) 6.85K to 6.61K | 2% |
| 28-Mar-23 4:02 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 24-Mar-23 | Option Exercise | 333 | -- | -- | 5% 6.52K to 6.85K | |
| 09-Mar-23 4:00 PM View: | Sprague John M Chief Financial Officer | T2 Biosystems, Inc. (TTOO) | 28-Feb-23 | Planned Option Sale | 1,148 | $0.59 | $677.32 | (14%) 8.42K to 7.27K | |
| 09-Mar-23 4:00 PM View: | Sperzel John J III Chairman and CEO Director | T2 Biosystems, Inc. (TTOO) | 28-Feb-23 | Planned Option Sale | 2,898 | $0.59 | $1,709.82 | (14%) 20.23K to 17.33K | |
| 09-Mar-23 4:00 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 28-Feb-23 | Planned Option Sale | 1,585 | $0.59 | $935.15 | (20%) 8.1K to 6.52K | |
| 09-Mar-23 4:00 PM View: | Sprague John M Chief Financial Officer | T2 Biosystems, Inc. (TTOO) | 24-Feb-23 | Option Exercise | 2,914 | -- | -- | 53% 5.5K to 8.42K | |
| 09-Mar-23 4:00 PM View: | Sperzel John J III Chairman and CEO Director | T2 Biosystems, Inc. (TTOO) | 24-Feb-23 | Option Exercise | 6,667 | -- | -- | 49% 13.56K to 20.23K | |
| 09-Mar-23 4:00 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 24-Feb-23 | Option Exercise | 2,914 | -- | -- | 56% 5.19K to 8.1K | |
| 09-Mar-23 4:00 PM View: | Sprague John M Chief Financial Officer | T2 Biosystems, Inc. (TTOO) | 22-Feb-23 | Planned Option Sale | 1,545 | $0.65 | $1,004.25 | (22%) 7.05K to 5.5K | |
| 09-Mar-23 4:00 PM View: | Sperzel John J III Chairman and CEO Director | T2 Biosystems, Inc. (TTOO) | 22-Feb-23 | Planned Option Sale | 6,875 | $0.65 | $4,468.75 | (34%) 20.43K to 13.56K | |
| 09-Mar-23 4:00 PM View: | Giffin Brett A. Chief Commercial Officer | T2 Biosystems, Inc. (TTOO) | 22-Feb-23 | Planned Option Sale | 537 | $0.65 | $349.05 | (39%) 1.38K to 0.84K | |
| 09-Mar-23 4:00 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 22-Feb-23 | Planned Option Sale | 2,145 | $0.65 | $1,394.25 | (29%) 7.33K to 5.19K | |
| 09-Mar-23 4:00 PM View: | Sprague John M Chief Financial Officer | T2 Biosystems, Inc. (TTOO) | 20-Feb-23 | Option Exercise | 4,000 | -- | -- | 131% 3.05K to 7.05K | |
| 09-Mar-23 4:00 PM View: | Sperzel John J III Chairman and CEO Director | T2 Biosystems, Inc. (TTOO) | 20-Feb-23 | Option Exercise | 16,000 | -- | -- | 361% 4.43K to 20.43K | |
| 09-Mar-23 4:00 PM View: | Gibbs Michael Terrence General Counsel | T2 Biosystems, Inc. (TTOO) | 20-Feb-23 | Option Exercise | 4,000 | -- | -- | 120% 3.33K to 7.33K | |
| 09-Mar-23 4:00 PM View: | Giffin Brett A. Chief Commercial Officer | T2 Biosystems, Inc. (TTOO) | 20-Feb-23 | Option Exercise | 1,333 | -- | -- | 2962% 45 to 1.38K | |
| 16-Aug-23 4:01 PM View: | Bernard Thierry Director | T2 Biosystems, Inc. (TTOO) | 01-Jan-23 | Option Exercise | 1,550 | -- | -- | 51% 3.02K to 4.57K | |
| 16-Aug-23 4:00 PM View: | Saunders Ninfa Director | T2 Biosystems, Inc. (TTOO) | 01-Jan-23 | Option Exercise | 1,550 | -- | -- | 51% 3.02K to 4.57K | |
| 22-Nov-22 4:00 PM View: | Giffin Brett A. Chief Commercial Officer | T2 Biosystems, Inc. (TTOO) | 10-Nov-22 | Option Sale | 1,292 | $1.79 | $2,316.56 | (36%) 3.54K to 2.25K | |
| 22-Nov-22 4:00 PM View: | Giffin Brett A. Chief Commercial Officer | T2 Biosystems, Inc. (TTOO) | 08-Nov-22 | Option Exercise | 3,333 | -- | -- | 1572% 0.21K to 3.54K |
